| P50 | author | Richard Weinshilboum | Q52447985 |
| | Krishna R Kalari | Q57034862 |
| | Kevin J Thompson | Q59692281 |
| | Zhenkun Lou | Q87718627 |
| | Liewei Wang | Q89121645 |
| | James N Ingle | Q89668737 |
| | Ann M Moyer | Q90669273 |
| | Judy Boughey | Q92381506 |
| | Matthew P Goetz | Q95259846 |
| | Alvaro Moreno-Aspitia | Q96172888 |
| | Vera J Suman | Q96186734 |
| | Jason P Sinnwell | Q100957801 |
| | Daniel W Visscher | Q108126317 |
| | Donald W Northfelt | Q116795045 |
| | Amy L Conners | Q116795054 |
| P2093 | author name string | Yan Lu | |
| | Katherine Minter-Dykhouse | |
| | Bo Qin | |
| | Ping Yin | |
| | Jia Yu | |
| | John A Copland | |
| | Xiaojia Tang | |
| | Richard J Gray | |
| | Laura A Marlow | |
| | Anthony Schweitzer | |
| | Bowen Gao | |
| | Sarah A McLaughlin | |
| | James L Miller | |
| | Jason Hubbard | |
| | Katie Hunt | |
| P2860 | cites work | A transmembrane intracellular estrogen receptor mediates rapid cell signaling | Q24294726 |
| | Patient-derived tumour xenografts as models for oncology drug development | Q24604068 |
| | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes | Q24630783 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Q24647928 |
| | Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice | Q24669724 |
| | Patient-derived xenograft models of breast cancer and their predictive power | Q27026531 |
| | A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer | Q27851787 |
| | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Genome remodelling in a basal-like breast cancer metastasis and xenograft | Q28395637 |
| | APE: Analyses of Phylogenetics and Evolution in R language | Q29546513 |
| | Cancer drug resistance: an evolving paradigm | Q29616694 |
| | American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer | Q30494798 |
| | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics | Q33330850 |
| | Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer | Q33614238 |
| | Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition | Q33739184 |
| | Establishment and genomic characterization of mouse xenografts of human primary prostate tumors | Q33745240 |
| | Transgenic mouse models of human breast cancer | Q34130558 |
| | Patient-derived xenograft models: an emerging platform for translational cancer research | Q34205518 |
| | Modelling breast cancer: one size does not fit all. | Q34667643 |
| | Overview of resistance to systemic therapy in patients with breast cancer | Q34712197 |
| | Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 | Q35130819 |
| | Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance | Q35558646 |
| | Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials | Q35740423 |
| | Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice | Q35765489 |
| | Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy | Q36025853 |
| | Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies. | Q36047387 |
| | Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine | Q36778929 |
| | Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. | Q36892577 |
| | Patient-derived breast tumor xenografts facilitating personalized cancer therapy | Q36903447 |
| | A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models | Q37067545 |
| | Critical choices for modeling breast cancer in transgenic mouse models. | Q37968500 |
| | Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis | Q38188183 |
| | High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. | Q38826826 |
| | Interrogating open issues in cancer precision medicine with patient-derived xenografts. | Q39095733 |
| | A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. | Q39751877 |
| | A new model of patient tumor-derived breast cancer xenografts for preclinical assays | Q40112517 |
| | Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse | Q41135046 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| | The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice | Q62963901 |
| | Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy | Q76383821 |
| | An in vivo platform for translational drug development in pancreatic cancer | Q80087890 |
| | Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts | Q82044929 |
| | Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations | Q84466734 |
| P433 | issue | 1 | |
| P921 | main subject | chemotherapy | Q974135 |
| | xenograft | Q64148587 |
| P304 | page(s) | 130 | |
| P577 | publication date | 2017-12-06 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study | |
| P478 | volume | 19 | |